Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation


Free Case Evaluation

NuvaRing Information

NuvaRing Lawsuits Updates

______________________________________________________________________________



UPDATE
: "Merck to pay $100 million in NuvaRing contraceptive settlement" (2/7/14, Reuters)

 

(2/10/14)


The Prather v. Organon case, 4:08 CV 558 RWS, which had been set to start trial in October 2013 has been rescheduled. The Prather NuvaRing trial will now be held on January 27, 2014, according to this latest Order by Judge Sippel.

From the conclusion of this same July 2013 Order:

IT IS FURTHER ORDERED that the parties are ordered to maintain regular and frequent contact with the mediator who will report the status of any negotiations to the Court.

(8/2/13) 


What is NuvaRing?

 

NuvaRing -- manufactured by Organon, Schering-Plough, and Merck --is the trade name for a combined hormonal contraceptive vaginal ring used for birth control. It contains ethinyl estradiol and etonogestrel, a metabolite of desogestrel, which has been recognized as a possibly dangerous progestin. NuvaRing has been associated with adverse side effects such as:

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Ischemic Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Myocardial Infarction (MI)
  • Death

 


 

Ten Most Recent NuvaRing Case Evaluations

NuvaRing - Bilateral Pulmonary Embolism (PE) - 21 yr old woman (8051)

NuvaRing - Pulmonary Embolism (PE) - 27 yr old woman (8036)

NuvaRing - Stroke (CVA); lost vision, no longer able to drive - 30 yr old woman (8024)

NuvaRing - Blood Clot-Related Splenic Infarct and Infarcted Kidney - 52 yr old woman (8017)

NuvaRing - Bilateral Pulmonary Embolism (PE) - 21 yr old woman (8009)

NuvaRing - Acute Limb Ischemia - 42 yr old woman (8007)

NuvaRing - Multiple Blood Clots in Brain - 20 yr old woman (7973)

NuvaRing - Deep Vein Thrombosis (DVT); required later surgery on vein - 44 yr old woman (7972) 

NuvaRing - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 26 yr old woman (7944)

NuvaRing - Pulmonary Embolism (PE) - 18 yr old woman (7873)

 


Free NuvaRing Case Evaluation


The information you provide to us for this Free Case Evaluation will be treated as strictly confidential.  You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.  Go to Form

 


Drug Injury Watch: NuvaRing News and Commentary

September 2013 NuvaRing Update By Merck Reveals More Than 1,700 Lawsuits Filed Since This Products Liability Litigation Started In 2007


Serious Injury And Death Cases Involve Blood Clots Leading To DVT And/Or PE Events As Well As Heart Attacks And Strokes In Women Of Various Age

SUMMARY: The Form 10-Q SEC filing by Merck for the corporate quarterly period ending September 30, 2013 (93 page PDF document) provides us with this latest information about the number of filed NuvaRing lawsuits: "As of September 30, 2013, there were approximately 1,715 NuvaRing cases."

In comparison, at the end of June 2013 there were approximately 1,500 NuvaRing cases.

My law firm has been involved with the NuvaRing litigation since it started in 2007. We will continue to monitor the NuvaRing litigation and report significant developments as they become publicly available.

[Read this article in full at original source]

 

Earlier NuvaRing articles by Tom Lamb on the Drug Injury Watch blog:

October 2013 NuvaRing Label Change: Warnings And Precautions Section Sets Forth Two Competing Medical Studies About Side Effects

NuvaRing: Merck Updates On The Number Of Cases Filed Against Drug Company As Of June 30, 2013

June 2013 NuvaRing Update: Significant Legal And Medical Developments From Past Year As Reported In Recent Articles

NuvaRing Update 2013: More NuvaRing Lawsuits Filed According To Merck Report; First NuvaRing Trial Dates Moved Back (Again)

Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

NuvaRing: Plaintiffs' Expert Reports Made Available By New Jersey Judge Based On Public's Right Of Access To Judicial Proceedings

Disturbing Information About NuvaRing Safety Found In Motions On Experts Recently Unsealed By Federal Court MDL Judge

New 2012 Medical Study Shows NuvaRing Doubles The Risk Of Stroke And Heart Attack, And The Degree Of Risk Increases With Age

Merck's NuvaRing Increases The Relative Risk For Blood-Clot Side Effects Says Medical Expert After Weighing Competing Studies

Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk

950 NuvaRing Lawsuits Pending As Of December 31, 2011 According To Merck Annual Report

Current First NuvaRing Trial Date: New Jersey State Court Bellwether Case Set For Early February 2013

NuvaRing Update: October 2011 FDA Study Finds Increased Risk Of Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT)

730 NuvaRing Lawsuits Filed As Of December 31, 2010 Per Merck Annual Report

NuvaRing Update: First Trial Dates In MDL And New Jersey Mass Tort Litigation Not Until 2012, Now

Medical Journal Report: Adverse Drug Reactions And Pulmonary Embolism Are Often Difficult For Doctors To Diagnose

WebMD List Of Symptoms For Serious Side Effects From Using Estrogen-Progestin Birth Control Methods

August 2008: NuvaRing MDL Created In Federal Court System, Eastern District Of Missouri  

More Reports Of Serious Blood Clots In Women Using Birth Control Patch Or Vaginal Ring  

More Reports of Women Who Had Venous Thromboembolic Events Associated With Their Use Of NuvaRing  

NuvaRing Birth Control Device Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack: Part Two  

NuvaRing Birth Control Device Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack: Part One

 


Is Your Birth Control as Safe as You Think?

Marie Claire magazine, June 2011 -- By Laura Beil

Since NuvaRing hit the market, more than 1500 women have filed lawsuits, claiming it has caused potentially life-threatening blood clots resulting in a DVT, PE, or stroke.

(Includes interview with drug injury attorney Tom Lamb.)

Read more: Birth Control Health Risks - Is the NuvaRing Dangerous? - Marie Claire


Drug Injury Law: Legal News and Information


First NuvaRing Lawsuit Trials Against Merck Are Currently Scheduled To Start In May 2013 (New Jersey State Court NuvaRing Mass Tort Consolidation) And July 2013 (Federal Court NuvaRing MDL)

The first bellwether, or test, trial in the New Jersey state court consolidation of NuvaRing lawsuits is currently scheduled to start on May 6, 2013. In the federal court NuvaRing MDL, the first bellwether trial is set to start on July 8, 2013.

New Research Finds 90% Increased Risk Of Blood Clots While Using NuvaRing Compared to Older Class Of Birth Control Pills Containing Levonorgestrel

In May 2012 medical studies about the safety of Merck's NuvaRing came to opposite conclusions. A study done by independent researchers found that compared to birth control pills the NuvaRing had a 90% greater risk of blood clots that cause deep vein thrombosis (DVT) and/or pulmonary embolism (PE). A study sponsored by drug company Merck found its vaginal ring posed no greater or 0% risk.

More Than 700 NuvaRing Lawsuits Filed Against Merck And Organon At Start Of 2011

As of December 31, 2010 there were approximately 730 NuvaRing cases filed against Merck and Organon. 610 NuvaRing lawsuits are pending in the federal court NuvaRing MDL and 110 cases have been filed in the New Jersey state court consolidation.

First NuvaRing Lawsuit Trials In Federal Court MDL And New Jersey State Court Expected To Be Scheduled For Summer 2011

The first NuvaRing trials for the hundreds of injury and death lawsuits that have been filed against Organon, Schering-Plough, and Merck are expected to be scheduled to start in the summer of 2011.


Judge Sippel Schedules A December 1, 2009 "Science Day" For NuvaRing MDL Litigation

MDL Judge Sippel will hear presentations on (1) the Plaintiffs’ theory about how the NuvaRing causes an increased risk of serious blood clots, and (2) drug company’s contention that the NuvaRing is not a dangerous nor unsafe birth control method.


Growing Number Of NuvaRing Lawsuits Results In Cases Being Centralized By Courts

In order to manage the hundreds of NuvaRing lawsuits, federal court system established the NuvaRing multidistrict litigation (MDL) in August 2008 and New Jersey state court system designated NuvaRing as a Mass Tort in March 2009.

NuvaRing MDL (Multidistrict Litigation) Likely To Be In Eastern District Of Missouri
In late April 2008 attorneys representing some of the women who have sued Organon USA Inc. and other pharmaceutical companies associated with the NuvaRing birth control device filed court papers seeking the establishment of a federal court multidistrict litigation, or MDL, for the NuvaRing litigation.

Is There A Safety Problem With NuvaRing And Why Are Lawsuits Being Filed?
As a result of case reports made by women and their doctors, NuvaRing use is associated with serious side effects resulting from blood clots, such pulmonary embolism (PE) and deep vein thrombosis (DVT) as well as strokes and heart attacks, with some events resulting in death.

NuvaRing Birth Control Device Use Can Cause Blood Clots and Related Serious Side Effects
NuvaRing contains etonogestrel, a metabolite of desogestrel, which has been recognized as a possibly dangerous progestin. An article published in the October 9, 2003 edition of The New England Journal of Medicine, “Combination Estrogen–Progestin Oral Contraceptives”, discusses how desogestrel is harmful.

Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery

For women who are using estrogen-progestin methods of birth contro, such as NuvaRing, here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.


NuvaRing Class Actions
We believe that people who suffered a serious injury or death due to the NuvaRing contraceptive are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any NuvaRing class action together with the claims of many other people who may have had different injuries caused by NuvaRing.

Legal Compensation for NuvaRing Injuries
If you experienced serious side effects from the use of NuvaRing, or a person died due to an adverse reaction while using NuvaRing birth control, you may have a claim for legal compensation. Legal compensation claims involving injuries or death caused by the use of NuvaRing are made by filing a lawsuit in court. All states have statutes of limitations that determine the time period allowed to file a NuvaRing lawsuit.

All content by attorney Tom Lamb


  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.